Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2002
12/04/2002EP1261605A1 Benzoxazole derivatives as tnf and pde iv inhibitors
12/04/2002EP1261601A1 Substituted indoles for modulating nfkb activity
12/04/2002EP1261600A1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
12/04/2002EP1261594A1 5,10-dihydroacridines as calcium channel blockers
12/04/2002EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
12/04/2002EP1261589A1 Imidazole compounds and their use as adenosine deaminase inhibitors
12/04/2002EP1261585A1 Substituted indole mannich bases
12/04/2002EP1261583A1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/04/2002EP1261579A1 Dehydroamino acids
12/04/2002EP1261378A2 Biodegradable immunomodulatory formulations and methods for use thereof
12/04/2002EP1261357A1 Isolation and transplantation of retinal stem cells
12/04/2002EP1261347A1 Therapeutic compositions and methods for treatingperiodontitis with antiinflamatory compounds
12/04/2002EP1261337A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
12/04/2002EP1261336A2 Il-8 receptor antagonists
12/04/2002EP1261334A1 Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation
12/04/2002EP1261329A2 Il-8 receptor antagonists
12/04/2002EP1261328A1 Il-8 receptor antagonists
12/04/2002EP1261324A2 Tramadol for the treatment of functional gastrointestinal disorders
12/04/2002EP1261320A2 Micellar pharmaceutical compositions for buccal and pulmonary application
12/04/2002EP1261309A1 Device for calculating elixir doses appropriate for a patient's weight
12/04/2002EP1180026B1 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
12/04/2002EP1131304B1 N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
12/04/2002EP1109529B1 Use of a lipid extract of the skeletonema algae
12/04/2002EP1097139B1 Quinoline derivatives
12/04/2002EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/04/2002EP0928291B1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
12/04/2002EP0853478B1 New n-acylated 4-hydroxyphenylamine derivatives with analgesic properties and pharmaceutical compositions containing them
12/04/2002EP0814837B1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis
12/04/2002EP0719285B1 Il8 inhibitors
12/04/2002CN1383450A Antibody molecules having specificity for huamn tumor necrosis factory alpha, and use thereof
12/04/2002CN1383386A Drug delivery device for insertion in vagina, rectum of nasal cavity
12/04/2002CN1382486A Fengshitongluo wan for treating rheumatism
12/04/2002CN1382476A Application of yellowstem milkwort in preparing medicines
12/04/2002CN1382465A 'Wugu' recovery ointment
12/04/2002CN1382462A Plaster for treating rheumatic or rheumatoid arthritis and its preparing process
12/04/2002CN1382459A Chinese-medicinal capsule for treating rheumatic or rheumatoid arthritis and its preparing process
12/04/2002CN1382436A Slowly releasing analgesic and its preparing process
12/04/2002CN1095377C Medicine for treating skin ringworm and dermatitis and prepn. process
12/04/2002CN1095372C Chinese medicinal preparation for treating rheumatism and atrophic arthritis, and its prepn. method
12/04/2002CN1095369C Capsule for treating wind-cold and wind-dampness syndrome
12/03/2002WO2001096365A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
12/03/2002US6489365 Ltb4-antagonistic compounds for treatment of inflammation, allergy or gastropathy induced by non-steroidal antiinflammatory agents in a warm-blooded animals
12/03/2002US6489353 Antiinflammatory agents; autoimmune diseases; central nervous system disorders
12/03/2002US6489349 Treating an autoimmune disorder with an alkylamine substituted pyridine
12/03/2002US6489339 C3A receptor ligands
12/03/2002US6489330 Or a bioprecursor, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of such as famciclovir; prophylactic treatment for kaposi's sarcoma or aids related disease
12/03/2002US6489327 Tryptase inhibitors
12/03/2002US6489326 Sodium nucleinate, 2-amino-1,2,3,4-tetrahydrophthalazine-1,4-dione sodium salt dihydrate, used as an immunomodulator, which also has antiinflammatory and antioxidant properties
12/03/2002US6489323 Inhibiting no production from l-arginine, as seen in disease states such as arthritis and systemic hypotension associated with septic and/or toxic shock
12/03/2002US6489298 Contulakin-G, analogs thereof and uses thereof
12/03/2002US6489130 Death associated kinase containing ankyrin repeats (DAKAR)
12/03/2002US6488964 Process for manufacturing coated gabapentin or pregabalin particles
12/03/2002US6488960 Corticosteroid formulation
12/03/2002US6488923 Inhibits elastase; inhibits inflammations; used for the preparation of a vasoregulatory and or collagen activating medicament and to treat gingivitis.
12/03/2002CA2414000A1 Pyridin-2-ylaminoalkylcarbonylglycyl-beta-alanine and derivatives
12/03/2002CA2216617C New flavone derivatives, their preparation procedures and the pharmaceutical compositions containing them
12/03/2002CA2100974C Layered mixed metal hydroxides for the stabilization of radioactive colloids
12/03/2002CA2074933C Thiazole derivatives as active superoxide radical inhibitors
11/2002
11/28/2002WO2002095391A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002WO2002095017A1 Novel mixed lineage kinase (7) (mlk7) polypeptide, polynucleotides encoding the same, and methods of use thereof
11/28/2002WO2002095015A1 Compounds capable of modulating the activity and stimulating the production of a catalytic antibody
11/28/2002WO2002095012A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders
11/28/2002WO2002095011A2 Inactivation of genes of the mep pathway
11/28/2002WO2002095007A2 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002WO2002094990A2 Receptors and membrane-associated proteins
11/28/2002WO2002094980A2 Phytocystatin
11/28/2002WO2002094876A2 Methods and compositions for treating respiratory mucin production associated disease conditions
11/28/2002WO2002094875A1 HAb18G/CD147, IT'S AGONIST AND APPLICATION
11/28/2002WO2002094833A1 Novel pyrrole derivatives as pharmaceutical agents
11/28/2002WO2002094825A1 Novel spiropiperidine derivative
11/28/2002WO2002094824A1 Pyridopyrimidine compounds and their uses
11/28/2002WO2002094823A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
11/28/2002WO2002094821A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002WO2002094813A1 Novel pyridyl cyanoguanidine compounds
11/28/2002WO2002094802A1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
11/28/2002WO2002094795A1 4-aminopyrimidine derivatives
11/28/2002WO2002094794A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002WO2002094790A1 Fused heterocyclic compound and medicinal use thereof
11/28/2002WO2002094783A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094764A1 Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use
11/28/2002WO2002094754A1 Vitamin d analogues
11/28/2002WO2002094304A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
11/28/2002WO2002094296A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/28/2002WO2002094294A1 A method of implanting heavy metal such as nobel metal, e.g. gold, and metal for use in implantation
11/28/2002WO2002094282A2 Compositions with methylprednisolone derivatives having therapeutic effect
11/28/2002WO2002094273A2 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
11/28/2002WO2002094270A2 Mip-1 alpha receptor ligands - drugs for t-cell mediated and autoimmune diseases
11/28/2002WO2002094266A1 Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity
11/28/2002WO2002094263A2 Caspase inhibitors and uses thereof
11/28/2002WO2002094261A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound
11/28/2002WO2002094257A1 Analgesic/antiinflammatory patches for topical use
11/28/2002WO2002094254A2 Abuse resistant pharmaceutical composition containing capsaicin
11/28/2002WO2002094236A1 Delivery of antipsychotics through an inhalation route
11/28/2002WO2002094220A1 Liquid pharmaceutical composition
11/28/2002WO2002094215A2 Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vimyl acetate as surface stabilizers
11/28/2002WO2002094210A2 Cosmetic agents
11/28/2002WO2002094203A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/28/2002WO2002094202A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
11/28/2002WO2002094193A1 Methods for inhibiting angiogenesis
11/28/2002WO2002094192A2 Antibodies against tumor necrosis factor delta (april)